Carnitine content and expression of mitochondrial β-oxidation enzymes in placentas of wild-type (OCTN2+/+) and OCTN2 null (OCTN2 -/-) mice

Pediatric Research

Volumn 56, Issue 3, 2004, Pages 323-328

  Shekhawat, Prem S ^a   Yang, Han Soo ^a   Bennett, Michael J ^b   Carter, Alva Lee ^a   Matern, Dietrich ^c   Tamai, Ikumi ^d   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Mayo Clinic   (United States)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CARNITINE; CARRIER PROTEIN; ENZYME; FATTY ACID; PROTEIN OCTN2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARNITINE DEFICIENCY; CATALYSIS; CONTROLLED STUDY; EMBRYO; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; FEMALE; FETUS; FETUS WEIGHT; GENE; GENOTYPE; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OCTN2 GENE; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA FUNCTION; PLACENTA WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; TANDEM MASS SPECTROMETRY; TROPHOBLAST;

EID: 4344611974     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000134252.02876.55     Document Type: Article

References (41)

1. Rinaldo P, Matern D, Bennett MJ 2002 Fatty acid oxidation disorders. Annu Rev Physiol 64:477-502
2. Bennett MJ, Rinaldo P, Strauss AW 2000 Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 37:1-44
3. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A 1998 Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382
4. Tein I 2003 Carnitine transport: pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis 26:147-169
5. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A 1999 Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94
6. Nikaido H, Horiuchi M, Hashimoto N, Saheki T, Hayakawa J 1995 Mapping of jvs (juvenile visceral steatosis) gene, which causes systemic carnitine deficiency in mice, on chromosome 11. Mamm Genome 6:369-370
7. Bernardini I, Evans MI, Nicolaides KH, Economides DL, Gahl WA 1991 The fetal concentrating index as a gestational age-independent measure of placental dysfunction in intrauterine growth retardation. Am J Obstet Gynecol 164:1481-1487; discussion 1487-1490
8. Bayes R, Campoy C, Goicoechea A, Peinado JM, Pedrosa T, Baena RM, Lopez C, Rivero M, Molina-Font JA 2001 Role of intrapartum hypoxia in carnitine nutritional status during the early neonatal period. Early Hum Dev 65:S103-S110
9. Kaufmann P, Scheffen I 1999 Placental development. In: Polin RA, Fox F (eds) Fetal and Neonatal Physiology. Saunders, New York, pp 47-56
10. Illsley NP 2000 Glucose transporters in the human placenta. Placenta 21:14-22
11. Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW 1999 A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340:1723-1731
12. Ibdah JA, Yang Z, Bennett MJ 2000 Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 71:182-189
13. Rinaldo P, Studinski AL, Matern D 2001 Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation. Prenat Diagn 21:52-54
14. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW 2003 Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 284:E1098-E1105
15. Oey NA, den Boer ME, Ruiter JP, Wanders RJ, Duran M, Waterham HR, Boer K, van der Post JA, Wijburg FA 2003 High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis 26:385-392
16. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V 1999 Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492
17. Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P, Burlina AB 1996 Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 39:185-188
18. Venizelos N, Ijlst L, Wanders RJ, Hagenfeldt L 1994 beta-Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria. Pediatr Res 36:111-114
19. Matern D, Magera MJ 2001 Mass spectrometry methods for metabolic and health assessment. J Nutr 131:1615S-1620S
20. Stevens RD, Hillman SL, Worthy S, Sanders D, Millington DS 2000 Assay for free and total carnitine in human plasma using tandem mass spectrometry. Clin Chem 46:727-729
21. Genger H, Enzelsberger H, Salzer H 1988 [Carnitine in therapy of placental insufficiency-initial experiences]. Z Geburtshilfe Perinatol 192:155-157
22. Tomomura M, Tomomura A, Musa DA, Horiuchi M, Takiguchi M, Mori M, Saheki T 1997 Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood. J Biochem (Tokyo) 121:172-177
23. Masuda M, Kobayashi K, Horiuchi M, Terazono H, Yoshimura N, Saheki T 1997 A novel gene suppressed in the ventricle of carnitine-deficient juvenile visceral steatosis mice. FEBS Lett 408:221-224
24. Athanassakis I, Mouratidou M, Sakka P, Evangeliou A, Spilioti M, Vassiliadis S 2001 L-carnitine modifies the humoral immune response in mice after in vitro or in vivo treatment. Int Immunopharmacol 1:1813-1822
25. Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, Barcellona ML 2000 L-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 16:99-104
26. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN 2002 Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A 99:1870-1875
27. Wainwright MS, Mannix MK, Brown J, Stumpf DA 2003 L-carnitine reduces brain injury after hypoxia-ischemia in newborn rats. Pediatr Res 54:688-695
28. Nakanishi T, Hatanaka T, Huang W, Prasad PD, Leibach FH, Ganapathy ME, Ganapathy V 2001 Na+- and Cl-coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol 532:297-304
29. Cramer S, Beveridge M, Kilberg M, Novak D 2002 Physiological importance of system A-mediated amino acid transport to rat fetal development. Am J Physiol Cell Physiol 282:C153-C160
30. Carter AL, Abney TO, Lapp DF 1995 Biosynthesis and metabolism of carnitine. J Child Neurol 10:S3-S7
31. Kurtz DM, Rinaldo P, Rhead WJ, Tian L, Millington DS, Vockley J, Hamm DA, Brix AE, Lindsey JR, Pinkert CA, O'Brien WE, Wood PA 1998 Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc Natl Acad Sci U S A 95:15592-15597
32. Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA 2001 Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet 10:2069-2077
33. Ibdah JA, Paul H, Zhao Y, Binford S, Salleng K, Cline M, Matern D, Bennett MJ, Rinaldo P, Strauss AW 2001 Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest 107:1403-1409
34. Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM, Boland R, Evans RM 2002 Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A 99:303-308
35. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM 1999 PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585-595
36. Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, Dey SK 1999 Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 13:1561-1574
37. Chirala SS, Chang H, Matzuk M, Abu-Elheiga L, Mao J, Mahon K, Finegold M, Wakil SJ 2003 Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc Natl Acad Sci U S A 100:6358-6363
38. Janssen U, Stoffel W 2002 Disruption of mitochondrial beta-oxidation of unsaturated fatty acids in the 3,2-trans-enoyl-CoA isomerase-deficient mouse. J Biol Chem 277:19579-19584
39. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL 1999 A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055-19062
40. Yang Z, Yamada J, Zhao Y, Strauss AW, Ibdah JA 2002 Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 288:2163-2166
41. Ibdah JA, Zhao Y, Viola J, Gibson B, Bennett MJ, Strauss AW 2001 Molecular prenatal diagnosis in families with fetal mitochondrial trifunctional protein mutations. J Pediatr 138:396-399